AKT1 and thyroid cancer: It is noteworthy that the dysregulation of the mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3 kinase (PI3K)/AKT signaling pathways represents the most common driver of thyroid cancer development and progression.